U. of Michigan Students to Lead, Livestream Marijuana Education Workshop
The future of the cannabis industry might be influenced by individuals who aren’t even old enough to legally purchase it.
Physicians, scientists, and researchers will gather on Sept. 29, 2018, for the first Green Wolverine Science Symposium in Ann Arbor, Michigan, to discuss the future of cannabis. The event, in collaboration with the University of Michigan College of Pharmacy and School of Nursing, will be open to the public and the topics of discussion include cannabis’ role in medicine — treating pain, sleep disorders, and post-traumatic stress disorder (PTSD) — as well as improving the marijuana industry’s research, development, and testing.
The symposium was organized by Green Wolverine, the first student business organization dedicated to networking and advancing cannabis industries’ education and opportunities. Founded by University of Michigan student Adam Rosenberg in early 2017, the nonprofit has about 350 members in chapters including University of California, Berkeley; University of Maryland; and Syracuse. (Disclosure: Weedmaps, Marijuana.com’s parent company, is on Green Wolverine’s board of advisors)
“I founded Green Wolverine immediately following the year where I spent six months working in a dispensary in Ann Arbor,” said, Rosenberg, a student in Michigan’s Ross School of Business. “It opened my eyes to the real professional opportunities that exist in the cannabis industry, which go so far beyond the dispensary and cultivation roles, but also the ancillary products and services.”
Rosenberg believes that providing students with a place to learn about cannabis and make industry connections will provide new job opportunities for his generation, and provide the industry with a young, educated, high-talent workforce. The Science Symposium is an extension of that vision.
“The main factor that differentiates our Science Symposium is that its completely organized and run by students,” Rosenberg told Marijuana.com. “The one impact I would like to see would be, through this event, really kickstarting additional research projects.”
Juan Aguirre, a senior in Michigan’s School of Nursing and Green Wolverine’s medical research chair, also has plans for entering the industry with a focus on medicinal cannabis.
“Cannabinoid-based medicines do have a place in Western pharmacology,” Aguirre told Marijuana.com three days before the event. Aguirre was on his way to print materials between classes. He said was extremely proud of the work he and his fellow students had done to put the Science Symposium together.
“Seeing one of my ideas come to fruition, where we’re having a conversation, talking about the science, and educating people, that’s one of the most fulfilling things I’ve done in my life thus far,” Aguirre said. “I was really happy about the response I got from the college pharmacy and school of nursing when I came to them with this idea, alongside Adam.”
Science Symposium schedule:
- 10 a.m. — Morning Opening Remarks
- 10:10 a.m. — The Great Cannabis Experiment: Dr. Marilyn Huestis, Ph.D. (former Chief of Chemistry and Drug Metabolism at NIDA’s Intramural Research Program)
- 10:40 a.m. — Slaying Dragons for Science – Navigating the Inexplicable Barriers to US Marijuana Efficacy Research: Dr. Sue Sisley, M.D. (Site Principal Investigator for the only FDA-approved randomized controlled trial examining safety/efficacy of whole plant marijuana in combat veterans with treatment-resistant PTSD)
- 11 a.m. — Cannabinoids to Treat Pain: Which One, What Dose, What Type of Pain?: Dr. Daniel Clauw, M.D. (University of Michigan Professor, Anesthesiology; Professor, Medicine (Rheumatology); Professor, Psychiatry)
- 11:20 a.m. — Use of Sublingual Administration of CBD & Palmitoylethanolamide for the Treatment of Mild to Moderate Pain: Dr. Debra Kimless, M.D. (Cannabis Medical Advisor at Pure Green)
- 11:40 a.m. — Understanding the Links Between Cannabis Use, Pain, Sleep, and Functioning in Adults Who Use Medical Cannabis in Michigan: Dr. Mark Ilgen, Ph.D. (Director, University of Michigan Addiction Treatment Services; Professor, Department of Psychiatry)
- Noon — Morning Panel Q&A
- 12:30 p.m. — Lunch Break
- 1:30 p.m. — Afternoon Opening Remarks and Panel Q&A
- 1:40 p.m. — The Health Impact of Cannabis: A Primer: Dr. Daniele Piomelli, Pharm.D., Ph.D. (Director, Institute for the Study of Cannabis; Professor, Anatomy and Neurobiology at University of California-Irvine School of Medicine; Louise Turner Arnold Chair in Neurosciences)
- 2:10 p.m. — Michigan Cannabis Research: Developing Sublingual, Transepidermal, and Water Solubilized Cannabinoid Therapies: Dr. Stephen Goldner, J.D. (FDA/NIH advisor; co-inventor of a liquid form of methadone)
- 2:30 p.m. — Cannabis-based Drug Delivery: University Lab to Clinical Trials: Dr. Audra Stinchcomb, Ph.D. (University of Maryland Professor, Pharmaceutical Sciences)
- 2:50 p.m. — Medical Cannabis Use in the Clinical Practice: Evan Litinas, M.D. (Chief Medical Officer at Om of Medicine)
- 3:10 p.m. — Efficacy and Safety of Epidiolex™ and Other Cannabidiol (CBD) Containing Botanical Products: Dr. Gus Rosania, Ph.D. (University of Michigan Professor, Pharmaceutical Sciences)
- 4 p.m.-4:20 p.m. — Closing Remarks